We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+37.47%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$343M
AUM Growth
+$44.3M
Cap. Flow
-$16.9M
Cap. Flow %
-4.94%
Top 10 Hldgs %
36.95%
Holding
100
New
31
Increased
17
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
SOLY
Soliton, Inc.
SOLY
+$10.1M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$9.42M
3
GLD icon
SPDR Gold Trust
GLD
+$9.03M
4
RCM
R1 RCM Inc. Common Stock
RCM
+$7.85M
5
COR icon
Cencora
COR
+$7.79M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$21.5M
2
NVST icon
Envista
NVST
+$12.8M
3
BSX icon
Boston Scientific
BSX
+$10.2M
4
AGN
Allergan plc
AGN
+$9.74M
5
BIIB icon
Biogen
BIIB
+$8.46M

Sector Composition

Rank Sector Weight
1 Healthcare 76.03%
2 Industrials 2.48%
3 Financials 0.92%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LITS
76
Lite Strategy Inc
LITS
$32.1M
$198K 0.06%
2,402
-121,853
-98% -$7.39M
BLCM
77
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$58K 0.02%
7,751
-4,521
-37% -$30.8K
FUSN
78
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$52K 0.02%
+3,000
New +$52.3K
ALKS icon
79
Alkermes
ALKS
$8.33B
– –
-170,042
Closed -$2.45M
AMGN icon
80
Amgen
AMGN
$210B
– –
-106,069
Closed -$21.5M
AMRN
81
Amarin Corp
AMRN
$302M
– –
-2,500
Closed -$200K
ASND icon
82
Ascendis Pharma A/S
ASND
$16B
– –
-13,889
Closed -$1.56M
HQY icon
83
HealthEquity
HQY
$8.78B
– –
-30,700
Closed -$1.55M
MD icon
84
Pediatrix Medical
MD
$2.03B
– –
-176,690
Closed -$2.06M
MEDP icon
85
Medpace
MEDP
$16.1B
– –
-20,858
Closed -$1.53M
MIRM icon
86
Mirum Pharmaceuticals
MIRM
$6.36B
– –
-10,701
Closed -$150K
NVST icon
87
Envista
NVST
$4.55B
– –
-856,922
Closed -$12.8M
SUPN icon
88
Supernus Pharmaceuticals
SUPN
$2.51B
– –
-25,000
Closed -$450K
UNH icon
89
UnitedHealth
UNH
$370B
– –
-21,900
Closed -$5.46M
VSTM icon
90
Verastem
VSTM
$511M
– –
-41,007
Closed -$1.3M
YARW
91
Yarrow Bioscience, Inc. Common Stock
YARW
$25.3M
– –
-6
Closed -$61K
WBA
92
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-69,400
Closed -$3.17M
ZBH icon
93
Zimmer Biomet
ZBH
$18.5B
– –
-48,410
Closed -$4.75M
NXGN
94
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
– –
-90,657
Closed -$946K
RVLP
95
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
– –
-575,000
Closed -$1.83M
SYNH
96
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-77,131
Closed -$3.04M
PRVB
97
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-42,100
Closed -$387K
SRRA
98
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-15,395
Closed -$151K
IMVTW
99
DELISTED
Immunovant, Inc. Warrants expiring 12/18/2024
IMVTW
– –
-307,700
Closed -$715K
AGN
100
DELISTED
Allergan plc
AGN
– –
-55,000
Closed -$9.74M
1 2 3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Sio Capital Management held 100 positions worth $343M, up 15% from $298M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sio Capital Management withdrew a net $16.9M in Q2 2020, closing 22 positions and reducing 28 holdings. Its most notable exit was Amgen, an estimated $21.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 84% a quarter earlier, followed by Industrials and Financials.

Against the trend, Sio Capital Management opened a new position in Soliton, Inc. worth $7.97M.

  • Sio Capital Management's largest Q2 2020 buy was Soliton, Inc.: 1,025,000 shares worth $7.97M.
  • Sio Capital Management added most to SPDR Gold Trust in Q2 2020, an estimated $9.03M increase.
  • Sio Capital Management's biggest Q2 2020 reduction was Boston Scientific, cutting an estimated $10.2M.
  • Sio Capital Management fully exited Amgen in Q2 2020, selling an estimated $21.5M.
  • Sio Capital Management's ten largest holdings make up 37% of its $343M portfolio in Q2 2020.
  • Sio Capital Management opened 31 new positions and closed 22 in Q2 2020.
  • Sio Capital Management's portfolio value rose 15% quarter-over-quarter to $343M.

Based on Sio Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.